CompanyGraph
Straumann Holding AG
STMN · SIX Swiss · Switzerland
Price data from its 0QMV listing on LSE
straumann.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $19.56B, above the global median of $1.15B
- FinancialsAltman Z-Score 8.45: safe zone
- Interpretations6 currently firing — 2 · 4
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.07%Above 5Y avg (0.70%)
Annual Rate
CHF 1.00Paid annual
Payout Ratio
42.6%Sustainable
Consecutive Growth
4 yr
Paying Dividends
27 yr
Payback Period
93.2 yr
Last Ex-Dividend
Apr 21, 2026
Last Payment
Apr 16, 2025
Screen for this company's dividend patterns
Find other companies where the same dividend readings fire.
Three-Year Dividend Growth With Elevated Dividends-to-FCF And Dividend-Stress Composite Firing
→common dividends to free cash flow
dividend growth rate standard
dividends exceed fcf
Dividend Consistency With Dividend-Stress Composite Firing And Elevated Dividends-to-FCF
→common dividends to free cash flow
dividend consistency
dividends exceed fcf
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company return capital?
Diagnostic
Three-Year Dividend Growth With Elevated Dividends-to-FCF And Dividend-Stress Composite Firing
The dividend keeps rising — but for years it has cost more than the free cash flow that funds it.
Reads
Diagnostic
Dividend Consistency With Dividend-Stress Composite Firing And Elevated Dividends-to-FCF
The dividend has been paid regularly, and lately from more cash than the business frees.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
15.89BCHF19.56B · vs all stocks (USD)
Trailing P/E
45.87xvs Medical Instruments & Supplies peers
Revenue (TTM)
2.61BCHF3.21B · vs all stocks (USD)
Profit Margin
13.66%vs Medical Instruments & Supplies peers
Beta
1.38xvs all stocks
52-Week Change
-2.56%vs all stocks
Market Capitalization
15.89BCHF19.56B · vs all stocks (USD)
Enterprise Value
15.95BCHF19.63B · vs all stocks (USD)
Trailing P/E
45.87xvs Medical Instruments & Supplies peers
Forward P/E
26.86xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
6.15xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
7.41xvs Medical Instruments & Supplies peers
Enterprise to Revenue
6.12xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
21.25xvs Medical Instruments & Supplies peers
Profit Margin
13.66%vs Medical Instruments & Supplies peers
Operating Margin
23.76%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
11.08%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
17.01%vs Medical Instruments & Supplies peers
Revenue (TTM)
2.61BCHF3.21B · vs all stocks (USD)
Revenue per Share (TTM)
16.34CHFUpdated Aug 19, 2026Quarterly Revenue Growth
2.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.83BCHF2.25B · vs all stocks (USD)
EBITDA (TTM)
665.85MCHF819.65M · vs all stocks (USD)
Net Income (TTM)
356.71MCHF439.10M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-24.40%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
503.96MCHF620.37M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
343.69MCHF423.07M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.00CHFUpdated Aug 19, 2026Trailing Annual Dividend Yield
1.07%vs all stocks
5-Year Average Dividend Yield
0.70%vs all stocks
Payout Ratio
42.60%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
4.24MCHFFY2025 · Dec 31, 2025Revenue
2.61BCHFFY2025 · Dec 31, 2025Cost of Goods Sold
818.54MCHFFY2025 · Dec 31, 2025Gross Profit
1.79BCHFFY2025 · Dec 31, 2025Operating Income
549.24MCHF676.10M · vs all stocks (USD)
Pre-tax Income
455.07MCHFFY2025 · Dec 31, 2025Income Tax Expense
97.05MCHFFY2025 · Dec 31, 2025Net Income
357.23MCHFFY2025 · Dec 31, 2025EBIT
470.33MCHFFY2025 · Dec 31, 2025EBITDA (Income Statement)
666.23MCHFFY2025 · Dec 31, 2025Selling, General & Administrative
1.25BCHFFY2025 · Dec 31, 2025Non-operating Interest Income
7.35MCHFFY2025 · Dec 31, 2025Non-operating Interest Expense
15.26MCHFFY2025 · Dec 31, 2025Net Income from Continuing Operations
358.02MCHFFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.32MCHFFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CHFFY2025 · Dec 31, 2025Operating Cash Flow
253.81MCHFFY2025 · Dec 31, 2025Free Cash Flow
78.18MCHFFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
475.43MCHFFY2025 · Dec 31, 2025Starting Profit (CF Statement)
358.02MCHFFY2025 · Dec 31, 2025Stock-based Compensation
18.95MCHFFY2025 · Dec 31, 2025Other Non-cash Items
14.82MCHFFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-65.49MCHFFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-72.49MCHFFY2025 · Dec 31, 2025Capital Expenditures
-175.63MCHFFY2025 · Dec 31, 2025Net Intangibles (CF)
-47.82MCHFFY2025 · Dec 31, 2025Net Acquisitions
-73.75MCHFFY2025 · Dec 31, 2025Purchase of Investments
-41.34MCHFFY2025 · Dec 31, 2025Sale of Investments
57.31MCHFFY2025 · Dec 31, 2025Other Investing Activity
1.62MCHFFY2025 · Dec 31, 2025Net Investing Cash Flow
-231.80MCHFFY2025 · Dec 31, 2025Long-term Debt Issuance
278.83MCHFFY2025 · Dec 31, 2025Long-term Debt Payments
-202.89MCHFFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-190.08MCHFFY2025 · Dec 31, 2025Common Stock Repurchase
-24.56MCHFFY2025 · Dec 31, 2025Common Dividends Paid
-151.34MCHFFY2025 · Dec 31, 2025Other Financing Charges
-1.00KCHFFY2025 · Dec 31, 2025Net Financing Cash Flow
-278.15MCHFFY2025 · Dec 31, 2025Shares Outstanding
159.45MSharesUpdated Aug 19, 2026Float Shares
107.92MSharesUpdated Aug 19, 2026% Held by Insiders
28.80%vs all stocks
% Held by Institutions
41.77%vs all stocks
Total Cash (MRQ)
489.57MCHF602.65M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.07CHFUpdated Aug 19, 2026Total Debt (MRQ)
418.93MCHF515.70M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1935xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.21xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
13.55CHFUpdated Aug 19, 2026Total Assets
3.76BCHF4.63B · vs all stocks (USD)
Total Current Assets
1.65BCHFFY2025 · Dec 31, 2025Total Liabilities
1.59BCHFFY2025 · Dec 31, 2025Total Non-current Assets
2.11BCHFFY2025 · Dec 31, 2025Total Non-current Liabilities
849.81MCHFFY2025 · Dec 31, 2025Total Current Liabilities
743.61MCHFFY2025 · Dec 31, 2025Cash
461.44MCHFFY2025 · Dec 31, 2025Cash Equivalents
13.98MCHFFY2025 · Dec 31, 2025Cash & Cash Equivalents
475.43MCHFFY2025 · Dec 31, 2025Other Short-term Investments
14.14MCHFFY2025 · Dec 31, 2025Accounts Receivable
494.99MCHFFY2025 · Dec 31, 2025Inventory
476.14MCHFFY2025 · Dec 31, 2025Accounts Payable
208.60MCHFFY2025 · Dec 31, 2025Short-term Debt
21.51MCHFFY2025 · Dec 31, 2025Long-term Debt
397.42MCHFFY2025 · Dec 31, 2025Other Non-current Liabilities
210.16MCHFFY2025 · Dec 31, 2025Common Stock (Book)
1.59MCHFFY2025 · Dec 31, 2025Retained Earnings
2.88BCHFFY2025 · Dec 31, 2025Total Shareholders' Equity
2.16BCHF2.66B · vs all stocks (USD)
Treasury Stock
448.00KCHFFY2025 · Dec 31, 202552-Week Low
73.02CHFUpdated Aug 19, 202652-Week High
109.80CHFUpdated Aug 19, 202652-Week Change
-2.56%vs all stocks
Beta
1.38xvs all stocks
50-Day MA
101.99CHFUpdated Aug 19, 2026200-Day MA
93.95CHFUpdated Aug 19, 2026Avg 10-Day Volume
235.19KSharesUpdated Aug 19, 2026Avg 30-Day Volume
248.14KSharesUpdated Aug 19, 2026Diluted EPS (TTM)
2.19CHFUpdated Aug 19, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Three Asset-Base Ratios Elevated
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 8.45: safe zoneNotable
Altman Z-Score: 8.45
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $19.56B, above the global median of $1.15BNotable
Market cap (USD): 19,561,339,737.861Global Median: 1,146,734,693.424
Revenue is $3.21B, above the global median of $520.53MNotable
Revenue (USD): 3,207,186,547.118Global Median: 520,528,949.311
Levered free cash flow is $423.07M, above the global median of $16.24MNotable
Levered free cash flow (USD): 423,073,054.24Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Hyosung Heavy Industries Corporation
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Fortum Oyj
Tier 1ProductionThroughput-Bound ConversionRuleFlow
China Longyuan Power Group Corporation Limited
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Knorr-Bremse AG
Tier 1ProductionThroughput-Bound ConversionRiskRule
Coloplast A/S
Tier 1ProductionThroughput-Bound ConversionRule
International Paper Company
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hd Hyundai Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Ruijie Networks Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Lennox International Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Amcor plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
XPEL, Inc.
4 interpretationsROE, ROA, And Operating ROA ElevatedIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Asset-Base Ratios Elevated
Harmony Biosciences Holdings, Inc.
4 interpretationsROE, ROA, And Operating ROA ElevatedIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Asset-Base Ratios Elevated
The Sherwin-Williams Company
4 interpretationsROE, ROA, And Operating ROA ElevatedIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Asset-Base Ratios Elevated